Sydney Research highlighted the leading-edge work being conducted by YY (Hui Xin Ong) in a July news headline. The article highlights a new advanced lung epithelial model, based on the Calu-3 cell line, that is now being used by YY and her team for routine analysis of inhaled antibiotics. YY is from the Respiratory Technology Group at the Woolcock Institute.
Sydney Research is one of the largest research hubs in NSW. Key to this alliance is the partnership between Sydney Local Health District and its principal tertiary referral hospitals - Royal Prince Alfred and Concord Hospitals, the University of Sydney and 11 eminent medical research institutes, including the Woolcock Institute of Medical Research. You can learn more about Sydney Research here